[Primary prevention with enhancer substances for a longer and healthier life]

Neuropsychopharmacol Hung. 2013 Jun;15(2):58-9.
[Article in Hungarian]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Aging / drug effects*
  • Aging / metabolism
  • Antiparkinson Agents / administration & dosage
  • Antiparkinson Agents / therapeutic use*
  • Chronic Disease / prevention & control*
  • Disease Progression
  • Education, Medical / trends
  • Feeding Behavior
  • Humans
  • Hungary
  • Life Expectancy
  • Life Style
  • Monoamine Oxidase Inhibitors / administration & dosage
  • Monoamine Oxidase Inhibitors / adverse effects
  • Neuroprotective Agents / therapeutic use*
  • Parkinson Disease / metabolism
  • Parkinson Disease / prevention & control*
  • Primary Prevention / education
  • Primary Prevention / methods*
  • Secondary Prevention
  • Selegiline / administration & dosage
  • Selegiline / therapeutic use*
  • Tertiary Prevention

Substances

  • Antiparkinson Agents
  • Monoamine Oxidase Inhibitors
  • Neuroprotective Agents
  • Selegiline